| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0051537 | MF | 2 iron, 2 sulfur cluster binding | Interacting selectively and non-covalently with a 2 iron, 2 sulfur (2Fe-2S) cluster; this cluster consists of two iron atoms, with two inorganic sulfur atoms found between the irons and acting as bridging ligands. |
FDX1, NDUFV2, SDHB, NDUFS1, UQCRFS1, XDH, AOX1, FXN, FDX1L, CISD2, ISCA1, GLRX2, CISD1 |
GO:0051538 | MF | 3 iron, 4 sulfur cluster binding | Interacting selectively and non-covalently with a 3 iron, 4 sulfur (3Fe-4S) cluster; this cluster consists of three iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands. It is essentially a 4Fe-4S cluster with one iron missing. |
SDHB, ACO2 |
GO:0051539 | MF | 4 iron, 4 sulfur cluster binding | Interacting selectively and non-covalently with a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands. |
NDUFS8, REV3L, NDUFS2, POLA1, ERCC2, SDHB, NDUFS1, POLD1, PRIM2, DNA2, NTHL1, PPAT, POLE, DPYD, ETFDH, CDKAL1, NUBPL, ACO2, ISCA1, MUTYH, NFU1 |
GO:0051541 | BP | elastin metabolic process | The chemical reactions and pathways involving elastin, a glycoprotein which is randomly coiled and crosslinked to form elastic fibers that are found in connective tissue. |
HIF1A |
GO:0051545 | BP | negative regulation of elastin biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of elastin. |
HBEGF |
GO:0051546 | BP | keratinocyte migration | The directed movement of a keratinocyte, epidermal cells which synthesize keratin, from one site to another. |
KRT16, PPARD, FERMT1 |
GO:0051549 | BP | positive regulation of keratinocyte migration | Any process that activates or increases the frequency, rate or extent of keratinocyte migration. |
MMP9, FGF7, ADAM9, HAS2, HBEGF, EPB41L4B |
GO:0051552 | BP | flavone metabolic process | The chemical reactions and pathways involving flavones, a class of pigmented plant compounds based on 2-phenyl-4H-1-benzopyran-4-one (2-phenylchromone). |
PPARGC1A |
GO:0051560 | BP | mitochondrial calcium ion homeostasis | Any process involved in the maintenance of an internal steady state of calcium ions within the cytoplasm of a cell or between mitochondria and their surroundings. |
ANXA6, MICU2 |
GO:0051561 | BP | positive regulation of mitochondrial calcium ion concentration | Any process that increases the concentration of calcium ions in mitochondria. |
TGM2, BCAP31, RAP1GDS1, MICU2, MCUR1 |
GO:0051562 | BP | negative regulation of mitochondrial calcium ion concentration | Any process that decreases the concentration of calcium ions in mitochondria. |
MICU2 |
GO:0051563 | BP | smooth endoplasmic reticulum calcium ion homeostasis | Any process involved in the maintenance of an internal steady state of calcium ions within the smooth endoplasmic reticulum of a cell or between the smooth endoplasmic reticulum and its surroundings. |
APP, PSEN1 |
GO:0051567 | BP | histone H3-K9 methylation | The modification of histone H3 by addition of one or more methyl groups to lysine at position 9 of the histone. |
EHMT2, SETDB2 |
GO:0051568 | BP | histone H3-K4 methylation | The modification of histone H3 by addition of one or more methyl groups to lysine at position 4 of the histone. |
KDM6A, RBBP5, KMT2E, KMT2C, ASH1L, ASH2L, KMT2B |
GO:0051569 | BP | regulation of histone H3-K4 methylation | Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3. |
CTCFL, PYGO2, ZNF335, KMT2B |
GO:0051570 | BP | regulation of histone H3-K9 methylation | Any process that modulates the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3. |
SETD7 |
GO:0051571 | BP | positive regulation of histone H3-K4 methylation | Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3. |
OGT, GCG, DNMT1, CTNNB1, BRCA1, SMAD4, RTF1, DNMT3B |
GO:0051572 | BP | negative regulation of histone H3-K4 methylation | Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3. |
KDM1A, H2AFY, BRCA1 |
GO:0051573 | BP | negative regulation of histone H3-K9 methylation | Any process that stops, prevents, or reduces the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3. |
KDM1A, DNMT1, BRCA1, DNMT3B |
GO:0051574 | BP | positive regulation of histone H3-K9 methylation | Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 9 of histone H3. |
BRCA1 |
GO:0051575 | MF | 5'-deoxyribose-5-phosphate lyase activity | Catalysis of the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site in DNA where a DNA-(apurinic or apyrimidinic site) lyase has already cleaved the C-O-P bond 3' to the apurinic or apyrimidinic site. |
POLQ, XRCC5, HMGA2 |
GO:0051582 | BP | positive regulation of neurotransmitter uptake | Any process that activates or increases the frequency, rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell. |
PARK2 |
GO:0051583 | BP | dopamine uptake involved in synaptic transmission | The directed movement of dopamine into a presynaptic neuron or glial cell. In this context, dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. |
PARK2, SNCA |
GO:0051584 | BP | regulation of dopamine uptake involved in synaptic transmission | Any process that modulates the frequency, rate or extent of the directed movement of the catecholamine neurotransmitter dopamine into a cell. |
TOR1A, DRD2 |
GO:0051585 | BP | negative regulation of dopamine uptake involved in synaptic transmission | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of dopamine into a presynaptic neuron or glial cell. |
SNCA |
GO:0051586 | BP | positive regulation of dopamine uptake involved in synaptic transmission | Any process that activates or increases the frequency, rate or extent of the directed movement of dopamine into a cell. |
DRD2, RAB3B |
GO:0051591 | BP | response to cAMP | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
PER1, NDUFS4, PAX4, LDHA, FOS, COL1A1, JUN, SPARC, TYR, FOSL1, AREG, NME1, PFKFB1, JUNB, JUND, SDC1, AGXT, DUSP1, BSG, SREBF1, PLA2G5, FOSB, TEK, CREM, RELA, PDE3A, CDO1, CARM1, PPARGC1B, MMP19, CITED1, DUOX2, DUOX1 |
GO:0051592 | BP | response to calcium ion | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
PTGES, AHCYL1, PDCD6, ENTPD6, SLC25A12, SEC31A, EGFR, PENK, FGA, FGB, FGG, IL6, THBS1, SPARC, SDC1, CAPN3, DUSP1, SLC6A1, GDI1, TRPC1, ANXA11, CALM2, CAV1, PPP3CA, KCNMA1, ADAM9, TRPC3, HNRNPD, ITPR3, HOMER1, TPH2, TTN, AQP3, BAD, S100A16, TRPV6, TXNIP, SLC25A13 |
GO:0051593 | BP | response to folic acid | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus. |
TYMS, EEF2, MTHFR, ASCL1 |
GO:0051597 | BP | response to methylmercury | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylmercury stimulus. |
S100B, ALAD, ARSB, CPOX, ANK2 |
GO:0051598 | BP | meiotic recombination checkpoint | A checkpoint that acts during late prophase I (pachytene) and prevents segregation of homologous chromosomes until recombination is completed, ensuring proper distribution of the genetic material to the gametes. |
RAD1 |
GO:0051599 | BP | response to hydrostatic pressure | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrostatic pressure stimulus. Hydrostatic pressure is the force acting on an object in a system where the fluid is at rest (as opposed to moving). The weight of the fluid above the object creates pressure on it. |
NTRK1, KRT8, ATP2B4, COL18A1 |
GO:0051601 | BP | exocyst localization | Any process in which an exocyst is transported to, or maintained in, a specific location. An exocyst is a protein complex peripherally associated with the plasma membrane that determines where vesicles dock and fuse. |
EXOC3, TNFAIP2, STXBP6, EXOC1 |
GO:0051602 | BP | response to electrical stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus. |
MSTN, NTRK1, IL6, TH, CD14, BTG2, EEF1A2, HNRNPD, S100A13 |
GO:0051603 | BP | proteolysis involved in cellular protein catabolic process | The hydrolysis of a peptide bond or bonds within a protein as part of the chemical reactions and pathways resulting in the breakdown of a protein by individual cells. |
CLPX, CTSL, CTSB, CTSH, IDE, CTSS, CTSK, CTSC, ADAMTS12, DNAJC3, CASP8, CLPP, SCPEP1, CTSZ, CTSF, ADAMTS7 |
GO:0051604 | BP | protein maturation | Any process leading to the attainment of the full functional capacity of a protein. |
SNAPIN, HSPD1, SERPINH1, TSPAN5, TSPAN14, SORL1, LMF1, STUB1 |
GO:0051606 | BP | detection of stimulus | The series of events in which a stimulus is received by a cell or organism and converted into a molecular signal. |
CADM1 |
GO:0051607 | BP | defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
PLSCR1, POLR3G, TLR3, BNIP3L, CRCP, IL33, IFNA1 , IFNA16, ISG15, IL6, PTPRC, BCL2, IRF1, IFITM1, IFNAR1, GBP1, IFNAR2, STAT2, F2RL1, ADARB1, IRF9, IFITM3, RELA, RNASEL, IL10RB, BST2, HYAL2, ILF3, BNIP3, FADD, DNAJC3, IFIT5, SERINC3, PMAIP1, TRIM25, IFI16, MICA, NCBP3, IFI44L, MAVS, SERINC5, NLRC5, IFNE, TRIM22, LILRB1, ISG20, ITCH, LYST, SPON2, POLR3C, TRIM34, GBP3, POLR3F, APOBEC3G, GPAM, EXOSC4, POLR3B, DDIT4, EIF2AK4, DMBT1, APOBEC3B, TBK1, PYCARD, POLR3K, SAMHD1, ZNF175 |
GO:0051612 | BP | negative regulation of serotonin uptake | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of serotonin into a cell. |
SNCA, GPM6B |
GO:0051615 | BP | histamine uptake | The directed movement of histamine into a cell, typically presynaptic neurons or glial cells. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans. |
SLC22A3 |
GO:0051622 | BP | negative regulation of norepinephrine uptake | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of norepinephrine into a cell. |
SNCA |
GO:0051638 | BP | barbed-end actin filament uncapping | The removal of capping protein from the barbed (or plus) end of actin filaments to free the ends for addition, exchange or removal of further actin subunits. |
LRRC16A |
GO:0051639 | BP | actin filament network formation | The assembly of a network of actin filaments; actin filaments on different axes and with differing orientations are crosslinked together to form a mesh of filaments. |
COBL, ACTN1, LCP1, PLS1, COBLL1, LRRC16A |
GO:0051640 | BP | organelle localization | Any process in which an organelle is transported to, and/or maintained in, a specific location. |
STX7 |
GO:0051641 | BP | cellular localization | A localization process that takes place at the cellular level; as a result of a cellular localization process, a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within or in the membrane of a cell. |
MYO1D |
GO:0051642 | BP | centrosome localization | Any process in which a centrosome is transported to, and/or maintained in, a specific location within the cell. |
AURKA, DYNC1LI2, PLXNA2, NIN, SYNE2, NDEL1, NDE1, SUN2 |
GO:0051643 | BP | endoplasmic reticulum localization | Any process in which endoplasmic reticulum is transported to, and/or maintained in, a specific location within the cell. |
MYO5A |
GO:0051645 | BP | Golgi localization | Any process in which the Golgi is transported to, and/or maintained in, a specific location within the cell. |
DAB1, STK11, HOOK3 |
GO:0051646 | BP | mitochondrion localization | Any process in which a mitochondrion or mitochondria are transported to, and/or maintained in, a specific location within the cell. |
MFN2, PLIN5, BRAT1, HDAC6 |
GO:0051647 | BP | nucleus localization | Any process in which the nucleus is transported to, and/or maintained in, a specific location within the cell. |
BIN1 |
GO:0051649 | BP | establishment of localization in cell | Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation. |
ZWINT |
GO:0051650 | BP | establishment of vesicle localization | The directed movement of a vesicle to a specific location. |
RAB11A |
GO:0051651 | BP | maintenance of location in cell | Any process in which a substance or cellular entity, such as a protein complex or organelle, is maintained in a specific location within, or in the membrane of, a cell, and is prevented from moving elsewhere. |
APOE |
GO:0051653 | BP | spindle localization | Any process in which is the spindle is transported to, and/or maintained in, a specific location. |
WASL, ACTR3, ACTR2, ASPM |
GO:0051654 | BP | establishment of mitochondrion localization | The directed movement of the mitochondrion to a specific location. |
FEZ1 |
GO:0051656 | BP | establishment of organelle localization | The directed movement of an organelle to a specific location. |
CROCC |
GO:0051659 | BP | maintenance of mitochondrion location | Any process in which a mitochondrion is maintained in a specific location within a cell and prevented from moving elsewhere. |
ALB |
GO:0051660 | BP | establishment of centrosome localization | The directed movement of the centrosome to a specific location. |
EZR, DLG1 |
GO:0051661 | BP | maintenance of centrosome location | Any process in which a centrosome is maintained in a specific location within a cell and prevented from moving elsewhere. |
GPSM2, ASPM, TBCCD1 |
GO:0051665 | BP | membrane raft localization | Any process in which membrane rafts are transported to, or maintained in, a specific location. Membrane rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. |
RALA |
GO:0051668 | BP | localization within membrane | Any process in which a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a membrane. |
CDH13, RAC1 |
GO:0051683 | BP | establishment of Golgi localization | The directed movement of the Golgi to a specific location. |
CDC42, YWHAZ, ARHGAP21, PDCD10, COPG1 |
GO:0051684 | BP | maintenance of Golgi location | Any process in which the Golgi is maintained in a specific location within a cell and prevented from moving elsewhere. |
ARHGAP21, TBCCD1 |
GO:0051693 | BP | actin filament capping | The binding of a protein or protein complex to the end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits. |
SPTBN1, SPTBN4 |
GO:0051694 | BP | pointed-end actin filament capping | The binding of a protein or protein complex to the pointed (or minus) end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits. |
TMOD1, LMOD1 |
GO:0051695 | BP | actin filament uncapping | The removal of capping protein from the end of actin filaments to free the ends for addition, exchange or removal of further actin subunits. |
ACTN2 |
GO:0051702 | BP | interaction with symbiont | An interaction between two organisms living together in more or less intimate association. The term symbiont is used for the smaller (macro) of the two members of a symbiosis; the various forms of symbiosis include parasitism, commensalism and mutualism. |
GPX1 |
GO:0051707 | BP | response to other organism | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism. |
KRT8 |
GO:0051716 | BP | cellular response to stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus by a cell and ends with a change in state or activity or the cell. |
EIF2B1, EIF2B3, EIF2B4 |
GO:0051717 | MF | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity | Catalysis of the reaction: inositol-1,3,4,5-tetrakisphosphate + H2O = inositol-1,4,5-trisphosphate + phosphate. |
PTEN, MINPP1 |
GO:0051718 | MF | DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates | Catalysis of the reaction: S-adenosyl-L-methionine + CpG (in DNA) = S-adenosyl-L-homocysteine + 5-MeCpG (in DNA). |
DNMT3B |
GO:0051721 | MF | protein phosphatase 2A binding | Interacting selectively and non-covalently with the enzyme protein phosphatase 2A. |
ENSA, HMGCR, TP53, BCL2, AKT1, ARPP19, IGBP1, FOXO1, STRN3, EIF4EBP1, PPP2R4, ANKLE2, MASTL, STRN4, SPHK1, CTTNBP2NL, SMG5, PPME1 |
GO:0051722 | MF | protein C-terminal methylesterase activity | Catalysis of the reaction: C-terminal protein amino acid methyl ester + H2O = protein amino acid + methanol. |
PPME1 |
GO:0051724 | MF | NAD transporter activity | Enables the directed movement of nicotinamide adenine dinucleotide into, out of or within a cell, or between cells; transport may be of either the oxidized form, NAD, or the reduced form, NADH. |
SLC25A17 |
GO:0051725 | BP | protein de-ADP-ribosylation | The process of removing one or more ADP-ribose residues from a protein. |
MACROD2, ADPRH, MACROD1 |
GO:0051726 | BP | regulation of cell cycle | Any process that modulates the rate or extent of progression through the cell cycle. |
CLIC1, ARNTL, GADD45B, RAD51D, CCNB2, GADD45G, INHA, JUN, ITGB1, PTPRC, MYBL2, IRF1, BCR, CCNB1, JUNB, JUND, SON, MAK, CDK11B, RBL1, WEE1, CDC25A, CDC25C, GRK5, STAT3, LEP, CDK8, CENPF, TSC2, PLK1, RACK1, ADARB1, CDK3, CDK16, ID3, FOXM1, RBBP4, EP300, TARDBP, SRSF5, SKP2, CCNI, BOP1, E2F2, PUM1, KIAA0101, CCNG2, LIN52, SIRT2, PHACTR4, BAP1, MASTL, LIN37, PRR11, UHRF2, MNT, PKMYT1, CDK19, BEX2, HIPK2, TXLNG, CDK12, DTL, CDK11A, L3MBTL1 |
GO:0051754 | BP | meiotic sister chromatid cohesion, centromeric | The cell cycle process in which centromeres of sister chromatids are joined during meiosis. |
RAD21, PPP2R1A, SGOL2 |
GO:0051758 | BP | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation | The directed movement of homologous chromosomes from the center of the spindle towards the spindle poles, mediated by the shortening of microtubules attached to the chromosomes, that contributes to meiosis I. |
FMN2 |
GO:0051764 | BP | actin crosslink formation | The process in which two or more actin filaments are connected together by proteins that act as crosslinks between the filaments. The crosslinked filaments may be on the same or differing axes. |
ACTN1, LCP1, FLNA, EPS8, DPYSL3, PLS1, BAIAP2L1 |
GO:0051770 | BP | positive regulation of nitric-oxide synthase biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric oxide synthase enzyme. |
TLR4, TLR2, JAK2, CCL2, NAMPT, MAP2K6, CCL20 |
GO:0051771 | BP | negative regulation of nitric-oxide synthase biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme. |
EDN1, GSTP1, PGGT1B, VIMP |
GO:0051775 | BP | response to redox state | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating redox state. Redox state refers to the balance of oxidized versus reduced forms of electron donors and acceptors in an organelle, cell or organ; plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleotides (NAD+/NADH and NADP+/NADPH) are among the most important. |
ARNTL, SIRT2, RYR2, NPAS2, VIMP, GLRX2 |
GO:0051781 | BP | positive regulation of cell division | Any process that activates or increases the frequency, rate or extent of cell division. |
ITGB1BP1, EREG, PDGFB, TGFA, TGFB1, IGF2, IL1A, IL1B, PPBP, PDGFA, FGF2, VEGFA, TAL1, MDK, FGF7, FGFR2, FGF9, BTC, THBS4, HTR2B, PGF, VEGFB, VEGFC, TGFB2, YBX1, CSPP1, SIRT2, PDGFD, GAREM1, PDGFC |
GO:0051782 | BP | negative regulation of cell division | Any process that stops, prevents, or reduces the frequency, rate or extent of cell division. |
MYC, BLM, PTCH1, TXNIP, INTU |
GO:0051787 | MF | misfolded protein binding | Interacting selectively and non-covalently with a misfolded protein. |
TOR1A, HSPD1, CLU, HSPA5, DNAJC3, DNAJC10, EDEM1, HDAC6, DNAJB9, STUB1 |
GO:0051788 | BP | response to misfolded protein | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a misfolded protein stimulus. |
CLU, HDAC6 |
GO:0051791 | BP | medium-chain fatty acid metabolic process | The chemical reactions and pathways involving medium-chain fatty acids, any fatty acid with a chain length of between C6 and C12. |
CROT |
GO:0051792 | BP | medium-chain fatty acid biosynthetic process | The chemical reactions and pathways resulting in the formation of any fatty acid with a chain length of between C6 and C12. |
ACOT7 |
GO:0051795 | BP | positive regulation of catagen | Any process that activates or increases the frequency, rate or extent of catagen, the regression phase of the hair cycle. |
GAL, TGFB2 |
GO:0051797 | BP | regulation of hair follicle development | Any process that modulates the frequency, rate or extent of hair follicle development. |
SMAD4, HPSE |
GO:0051798 | BP | positive regulation of hair follicle development | Any process that activates or increases the frequency, rate or extent of hair follicle development. |
TNF, FST, KRT17, TRADD, HPSE |
GO:0051800 | MF | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity | Catalysis of the reaction: phosphatidylinositol-3,4-bisphosphate + H2O = phosphatidylinositol-4-phosphate + phosphate. |
PTEN |
GO:0051823 | BP | regulation of synapse structural plasticity | Any process that modulates the frequency, rate or extent of synapse structural plasticity. Synapse structural plasticity is a type of cytoskeletal remodeling; this remodeling is induced by stimuli that can lead to long term potentiation and it can be activity-dependent or -independent. Examples of cytoskeletal changes include the formation of new spines and increase in spine size; this can be accompanied by the insertion of greater numbers of glutamate (or other neurotransmitter) receptors into the post-synaptic membrane. |
DRD2, CTNNA2, DMPK |
GO:0051835 | BP | positive regulation of synapse structural plasticity | Any process that activates, maintains or increases the frequency, rate or extent of synaptic structural plasticity. |
CDC42, CAMK1, FRMPD4 |
GO:0051861 | MF | glycolipid binding | Interacting selectively and non-covalently with a glycolipid, any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic group such as an acylglycerol, a sphingoid, a ceramide (N-acylsphingoid) or a prenyl phosphate. |
GLTP |
GO:0051864 | MF | histone demethylase activity (H3-K36 specific) | Catalysis of the reaction: histone H3 N6-methyl-L-lysine (position 36) + alpha-ketoglutarate + O2 = succinate + CO2 + formaldehyde + lysine. This reaction is the removal of a methyl group from lysine at position 36 of the histone H3 protein. |
KDM7A, KDM2A |
GO:0051865 | BP | protein autoubiquitination | The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. |
WWP2, PARK2, TRIM13, RNF8, TRIM37, UBE4B, CNOT4, RAG1, BRCA1, UBE2A, UBE2D3, UBE2B, RNF141, UHRF2, UHRF1, UBE2T, RAD18, RNF146, RNF181, AMFR, STUB1 |
GO:0051866 | BP | general adaptation syndrome | General adaptation syndrome is the set of changes in various organ systems of the body, especially the pituitary-endocrine system, in response to a wide range of strong external stimuli, both physiological and psychological. It is described as having three stages: alarm reaction, where the body detects the external stimulus; adaptation, where the body engages defensive countermeasures against the stressor; and exhaustion, where the body begins to run out of defenses. |
NR4A2 |
GO:0051867 | BP | general adaptation syndrome, behavioral process | The set of behavioral processes that occur as part of the general adaptation syndrome, the response of the body to a strong, stressful stimulus. |
PENK |
GO:0051870 | MF | methotrexate binding | Interacting selectively and non-covalently with methotrexate, an antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate reductase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. |
DHFR, FOLR1 |